Business Wire

CA-PSMF

17.2.2024 20:51:34 CET | Business Wire | Press release

Share
Patient Safety Movement Foundation Outlines 2024 Action Plan for Creating a Safer Healthcare System

At the Patient Safety Movement Foundation’s annual Mid-Year Event on January 26, patient safety experts from around the world participated in the creation of an action plan to eliminate preventable patient and healthcare worker harm. The Patient Safety Leadership Association was inaugurated by the Patient Safety Movement Foundation to respond to the need for a targeted forum for chief quality and patient safety officers and patient safety activists. The forum is a global executive network designed to champion the critical work of chief quality and patient safety officers within the healthcare system, supporting their efforts to implement evidence-based solutions and new technologies proven to save patient lives.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240217110649/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Dr. Mike Ramsay, CEO of the Patient Safety Movement Foundation, addresses attendees at the 2024 Mid-Year Event about the urgent steps the healthcare system needs to take to protect patient safety. (Photo: Business Wire)

The Patient Safety Leadership Association is expected to play a key role in furthering the action plan set forth at the Mid-Year Event. The plan’s action items include:

  • Seeking unwavering commitment from hospital governance boards and senior executives to champion a culture of patient safety within their institutions, while implementing a rigorous review process.
  • Actively involving patients and their families in crucial healthcare decisions in a manner that recognizes their invaluable perspectives and the critical roles they have to play in their own care.
  • Urging hospital leadership to foster a climate that prioritizes the well-being of healthcare employees and ensures a workplace that empowers, supports, and nurtures their resilience in the face of challenges.
  • Embracing the transformative potential of artificial intelligence to improve diagnostic accuracy and healthcare decision-making in response to recent data showing that misdiagnosis is a major contributor to medical errors.
  • Elevating the standard of safety for treating sick children, particularly during hospitalization, while increasing parent engagement.

The Patient Safety Leadership Association’s formation as a much-needed resource for advancing patient safety globally was strongly endorsed at the Mid-Year Event. The initiative empowers its members to discuss sensitive adverse events and to seek advice from world-renowned patient safety leaders, clinicians, and researchers. The knowledge thus gained can in turn be shared to the entire medical community via workshops, webinars, and symposia to develop transformative healthcare solutions.

“We now have the tools and know-how to make healthcare safe and, more importantly, the will to achieve it!” stated Dr. Michael Ramsay, Chief Executive Officer for the Patient Safety Movement Foundation.

More information about the Patient Safety Leadership Association is available on the Patient Safety Movement Foundation’s website at: https://psmf.org/patient-safety-leadership-association/.

ABOUT THE PATIENT SAFETY MOVEMENT FOUNDATION

In 2012, Joe Kiani founded the non-profit Patient Safety Movement Foundation (PSMF) to eliminate preventable medical errors in hospitals. His team worked with patient safety experts from around the world to create Actionable Evidence-Based Practices (AEBP) that address the top challenges. The AEBP are available without charge to hospitals online. Hospitals are encouraged to make a formal commitment to ZERO preventable deaths, and healthcare technology companies are asked to sign the Open Data Pledge to share their data so that predictive algorithms that can identify errors before they become fatal can be developed. The Foundation's annual World Patient Safety, Science & Technology Summit brings together all stakeholders, including patients, healthcare providers, medical technology companies, government employers, and private payers. The PSMF was established through the support of the Masimo Foundation for Ethics, Innovation, and Competition in Healthcare. For more information, please visit psmf.org.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240217110649/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Convatec Survey Challenges Assumptions About Leakage in Ostomy Care6.10.2026 09:00:00 CEST | Press release

New global findings highlight the role of peristomal skin health in improving outcomes and confidence for people living with an ostomy Convatec, a leading medical products and technologies company focused on solutions for the management of chronic conditions, today released Rethinking leakage in ostomy care, new international research highlighting a significant gap in how peristomal skin health is understood and managed in ostomy care. The findings indicate that skin health plays a critical role in preventing leakage, and supporting confidence in daily life, yet remains widely under-recognised in routine care. For many people, leakage is not only a clinical or product issue; it can shape whether they feel able to travel, exercise, socialise or take part fully in everyday life. More than half of respondents said they avoid such activities due to worry about their ostomy. The results of the survey, which included more than 1,800 people living with an ostomy and over 400 healthcare profes

Oulu2026 Boosts Tourism as Björk, Art and Technology Lead the European Capital of Culture Year’s Finale6.10.2026 09:00:00 CEST | Press release

The Oulu2026 European Capital of Culture programme has attracted visitors to northern Finland and contributed to strong tourism growth. According to Visit Oulu statistics, Oulu recorded nearly 475,000 registered overnight stays between January and August 2026, an increase of 12 per cent year on year. International overnight stays rose by 21 per cent to more than 96,600, while domestic overnight stays increased by 9 per cent. The trend continued in August, when international overnight stays grew by almost 29 per cent year on year. Hundreds of events combining art, technology, science, music, theatre and sport continue throughout the final months of 2026. “The programme’s diversity is clearest in the final months. There is something for culture enthusiasts and families alike, with experiences that cannot be found anywhere else. If ever there was a time to visit Oulu, it is now,” says Samu Forsblom, Programme Director of Oulu2026. A major highlight is the Lumo Art & Tech Festival, taking

Ant International and HSBC Expand Real-Time Treasury Management Services to the Middle East6.10.2026 08:30:00 CEST | Press release

Collaboration extends Ant International’s use of tokenised deposits in UAE, supporting faster treasury transactions Ant International today announced an expanded collaboration with HSBC to enhance real-time treasury management services in the Middle East. By leveraging HSBC’s global Tokenised Deposit Service (TDS), Ant International aims to improve the efficiency of its treasury operations across the region. As part of the collaboration, Ant International has successfully completed pilot transactions across two payment corridors connecting the United Arab Emirates and Hong Kong: Intra-UAE dirham transfers: Real-time, dirham-denominated tokenised deposit transactions within the UAE. Cross-border US dollar payments initiated from the UAE: US dollar-denominated tokenised deposit transfers between the UAE and international markets, including Hong Kong and Singapore. These transactions were initiated via WhaleRTP – Ant International’s proprietary, blockchain-based real-time treasury managem

RoslinCT Awarded £7.25 million Scottish Enterprise R&D Grant to Advance Digital Cell Therapy Manufacturing6.10.2026 08:00:00 CEST | Press release

RoslinCT, a leading global cell therapy Contract Development and Manufacturing Organization (CDMO), today announced it has been awarded a Research & Development grant from Scottish Enterprise to accelerate the digital transformation of its manufacturing operations in Scotland. The funding, supported by a Scottish Enterprise R&D grant of up to £7.25 million, forms part of RoslinCT's ambitious digital expansion plan, a multi-year initiative designed to enhance the company's integrated digital and AI capabilities and further strengthen Scotland's position as a global hub for advanced cell and gene therapy manufacturing. The programme will enable the development of a digitally integrated manufacturing environment, improving operational efficiency, data connectivity and manufacturing excellence across RoslinCT's operations. By creating a more connected and data-driven manufacturing environment, RoslinCT will be better positioned to support clients throughout the product lifecycle, helping b

30 Years of Restylane®: Reshaping the Aesthetics Field Through Science-Led, Patient-Centric Innovation6.10.2026 07:00:00 CEST | Press release

Galderma celebrates the 30th anniversary of Restylane, its pioneering range of hyaluronic acid (HA) injectables that established the category as the first to market1 With three decades of innovation across technology, packaging, and treatment areas, Restylane continues to meet growing aesthetic needs, including emerging areas such as medication-driven weight loss, skin quality and menopause1-11 This year’s milestones include the approvals of Restylane Shaype™ in the European Union (EU) for enhancement of the chin region, the new state-of-the-art Restylane syringe in the EU, United States (U.S.), and Canada, and Restylane Volyme™* in the U.S. for temple hollowing, with a dual-layer patent-pending technique leveraging both needle and cannula12-18 With more than 80 clinical trials, 180 publications, around 407,000 patients evaluated for safety, and 77 million treatments administered worldwide, Restylane remains a pioneer in science-backed aesthetic innovation and continues to shape the fu

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye